UnitedHealth Group's Q2 2015 earnings call revealed strong performance across the board, with 11.3% year-over-year revenue growth and 15% year-over-year net earnings growth. The company's Optum segment drove significant growth, with revenues increasing 16% and operating margins improving 20 basis points year-over-year. UnitedHealthcare also saw strong growth, with revenues growing 10% organically and operating margins steady at 6.1%. The company raised its 2015 revenue guidance to $154 billion and earnings guidance to $6.25-$6.35 per share, driven by core performance and the expected closing of the Catamaran transaction. Management expressed optimism about the company's prospects, citing its diversified portfolio, strong growth momentum, and ability to deliver value to customers.

[2]